chr5-122775135-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003100.4(SNX2):c.32G>T(p.Gly11Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000159 in 1,595,474 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003100.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SNX2 | NM_003100.4 | c.32G>T | p.Gly11Val | missense_variant | 1/15 | ENST00000379516.7 | NP_003091.2 | |
SNX2 | NM_001278199.1 | c.-871G>T | 5_prime_UTR_variant | 1/15 | NP_001265128.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SNX2 | ENST00000379516.7 | c.32G>T | p.Gly11Val | missense_variant | 1/15 | 1 | NM_003100.4 | ENSP00000368831.2 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000822 AC: 18AN: 218996Hom.: 0 AF XY: 0.0000937 AC XY: 11AN XY: 117434
GnomAD4 exome AF: 0.000167 AC: 241AN: 1443308Hom.: 0 Cov.: 29 AF XY: 0.000194 AC XY: 139AN XY: 715826
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2022 | The c.32G>T (p.G11V) alteration is located in exon 1 (coding exon 1) of the SNX2 gene. This alteration results from a G to T substitution at nucleotide position 32, causing the glycine (G) at amino acid position 11 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at